Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | RARB | P10826 | 7/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | RARA | P10276 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | MTOR | P42345 | 1/20 | 0.59 |
| ▸ | ESR1 | P03372 | 2/20 | 0.57 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.57 |
| ▸ | TACR2 | P21452 | 2/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.57 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | SHBG | P04278 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10528231 | 1.00 | HSD17B10 (0.61) | HSD17B10TSHRRARBALDH1A1RARA | |
| SCHEMBL8607022 | 1.00 | HSD17B10 (0.61) | HSD17B10TSHRRARBALDH1A1RARA | |
| SCHEMBL26226733 | 1.00 | HSD17B10 (0.61) | HSD17B10TSHRRARBALDH1A1RARA | |
| SCHEMBL10455067 | 1.00 | HSD17B10 (0.61) | HSD17B10TSHRRARBALDH1A1RARA | |
| SCHEMBL31270913 | 1.00 | HSD17B10 (0.61) | HSD17B10TSHRRARBALDH1A1RARA | |
| SCHEMBL22989786 | 1.00 | HSD17B10 (0.61) | HSD17B10TSHRRARBALDH1A1RARA | |
| SCHEMBL1599747 | 0.98 | RARB (0.58) | HSD17B10TSHRRARBALDH1A1RARA | |
| SCHEMBL15353198 | 0.94 | ESR1 (0.63) | HSD17B10TSHRALDH1A1ESR1ADRA2A | |
| SCHEMBL340275 | 0.94 | ESR1 (0.63) | HSD17B10TSHRALDH1A1ESR1ADRA2A | |
| SCHEMBL4191545 | 0.94 | ESR1 (0.63) | HSD17B10TSHRALDH1A1ESR1ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118834546-A | Electrochromic device and preparation method thereof | 吉林大学 | 2024-10-25 | — | — | CN | disclosed |
| CN-115745833-B | Preparation method of 4-alkyl-4' -cyanobiphenyl | 宁夏中星显示材料有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-115745833-A | Preparation method of 4-alkyl-4' -cyanobiphenyl | 宁夏中星显示材料有限公司 | 2023-03-07 | — | — | CN | disclosed |
| US-20080015223-A1 | Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto | ARENA PHARMACEUTICALS, INC. (US) | 2008-01-17 | — | — | US | disclosed |
| WO-2006060762-A2 | PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2006-06-08 | — | — | WO | disclosed |
| US-6605323-B1 | Monostable ferroelectric active matrix display | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) | 2003-08-12 | — | — | US | disclosed |
| EP-0788511-B1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-12-11 | — | — | EP | disclosed |
| US-6265536-B1 | MICROBIOCIDE AND FUNGICIDE WHICH IS INHIBITOR OF BETA-1,3-GLUCAN SYNTHASE; TREATMENT OF PNEUMOCYSTIS CARINII INFECTION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-07-24 | — | — | US | disclosed |
| EP-1086193-A1 | MONOSTABLE FERROELECTRIC ACTIVE MATRIX DISPLAY | Aventis Research & Technologies GmbH & Co. KG. (DE) | 2001-03-28 | — | — | EP | disclosed |
| US-6107458-A | FUNGICIDE WHICH IS BETA-1,3-GLYCAN SYNTHASE INHIBITOR; FOR PROPHYLAXIS AND TREATMENT OF PNEUMOCYSTIS CARINII INFECTIONS LIKE PNEUMONIA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-08-22 | — | — | US | disclosed |
| WO-1999064537-A1 | MONOSTABLE FERROELECTRIC ACTIVE MATRIX DISPLAY | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) | 1999-12-16 | — | — | WO | disclosed |
| US-5741438-A | Optically active biphenyl derivative, process for preparation thereof, liquid crystal composition containing the same as an effective component, and liquid crystal element using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-04-21 | — | — | US | disclosed |
| WO-1996011210-A1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-04-18 | — | — | WO | disclosed |
| US-5382380-A | Ferroelectric material for displays | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 1995-01-17 | — | — | US | disclosed |
| EP-0395390-B1 | Optically active biphenyl derivative, process for preparation thereof, liquid crystal composition containing the same as effective component, and liquid crystal element using the same | SUMITOMO CHEMICAL CO (JP) | 1994-09-28 | — | — | EP | disclosed |
| EP-0360042-B1 | p-Terphenyl derivatives and liquid crystalline compositions | KANTO KAGAKU (JP) | 1993-11-03 | — | — | EP | disclosed |
| EP-0395390-A1 | Optically active biphenyl derivative, process for preparation thereof, liquid crystal composition containing the same as effective component, and liquid crystal element using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1990-10-31 | — | — | EP | disclosed |
| EP-0360042-A1 | p-Terphenyl derivatives and liquid crystalline compositions | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 1990-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080015223-A1 | Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto | HTR5A, HTR2A, HTR3A | HSD17B10 3795/4885TSHR 114/4885RARB 1589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.